CANDEL THERAPEUTICS INC

NASDAQ: CADL (Candel Therapeutics, Inc.)

Last update: 3 hours ago

9.87

-0.36 (-3.52%)

Previous Close 10.23
Volume 977,570
Price / Sales 436.42
Price / Book 6.85
52 Weeks Range
4.35 (-55%) — 14.00 (41%)
Diluted EPS (TTM) -1.33
Total Debt/Equity (MRQ) 14.61%
Current Ratio (MRQ) 4.64
Operating Cash Flow (TTM) -27.20 M
Levered Free Cash Flow (TTM) -8.33 M
Return on Assets (TTM) -32.31%
Return on Equity (TTM) -98.14%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock Candel Therapeutics, Inc. Mixed Bullish

AIStockmoo Score

0.3
Analyst Consensus NA
Insider Activity NA
Price Volatility -1.0
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average 0.33

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
CADL - - - 6.85
SLNO 3 B - 135.77 5.57
PLUR - - - -
ARDX - - - 6.02
DARE - - - 29.40
ICCC - - - 2.87

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth
% Held by Insiders 17.53%
% Held by Institutions 40.72%

Ownership

Name Date Shares Held
Acorn Capital Advisors, Llc 30 Jun 2026 3,497,948
Portolan Capital Management, Llc 30 Jun 2026 3,490,398
Saturn V Capital Management Lp 30 Jun 2026 3,303,686
Halter Ferguson Financial Inc. 30 Jun 2026 772,461

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria